Chapter 51: Urinary Tract Disorder Drug Therapy

Urinary Tract Disorder Drug Therapy identifies Escherichia coli as the predominant pathogen in these conditions and outlines the pharmacokinetics and pharmacodynamics of various urinary antiseptics and antiinfectives. The text details the use of nitrofurantoin, which acts as a bacteriostatic or bactericidal agent depending on dosage, while warning of side effects like peripheral neuropathy and harmless brown urine discoloration. Considerable attention is given to methenamine, a prophylactic agent that requires a urine pH lesser than 5.5 to release bactericidal formaldehyde, and the importance of avoiding concurrent sulfonamide use to prevent crystalluria. The chapter examines the synergistic efficacy of trimethoprim-sulfamethoxazole (TMP-SMZ) in combating bacterial resistance, emphasizing the need for adequate hydration to mitigate renal complications. Fluoroquinolones, including ciprofloxacin and levofloxacin, are discussed as potent alternatives for complicated infections, though their use is restricted due to severe adverse reactions such as tendon rupture and exacerbation of myasthenia gravis. Beyond antiinfectives, the summary covers urinary analgesics like phenazopyridine, which alleviates dysuria and urgency but stains urine reddish-orange, potentially interfering with glucose testing. The discussion extends to functional bladder management, contrasting urinary stimulants like the cholinergic agonist bethanechol, used to treat urinary retention and neurogenic bladder, with antispasmodics and antimuscarinics such as oxybutynin, solifenacin, and tolterodine. These antimuscarinic agents are highlighted for their role in managing overactive bladder and urge incontinence by inhibiting parasympathetic nerve impulses, often leading to anticholinergic side effects like dry mouth, blurred vision, and constipation. Finally, the chapter integrates the nursing process, stressing the necessity of obtaining urine cultures prior to therapy, monitoring renal function, and educating patients on drug-specific dietary and safety precautions.